LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT – Regeneron Pharmaceuticals, Inc. Transaction History
LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT portfolio value:
$6.77M
portfolio value
LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -14.74% | -1.7K shares | -45K | $688.87 | 9.83K |
| Q2 2022 | share | Decrease | -1.70% | -200 shares | -1.37M | $591.13 | 11.53K |
| Q1 2022 | share | 0.00% | 0 shares | 786K | $698.42 | 11.73K | |
| Q4 2021 | share | Increase | +18.35% | 1.82K shares | 1.41M | $642.51 | 11.73K |
| Q3 2021 | share | Increase | +35.72% | 2.61K shares | 1.91M | $605.18 | 9.91K |
| Q2 2021 | share | Increase | +5.79% | 400 shares | 813K | $558.54 | 7.30K |
| Q1 2021 | share | Increase | +13.10% | 800 shares | 319K | $473.14 | 6.90K |
| Q4 2020 | share | Increase | +10.90% | 600 shares | -133K | $483.11 | 6.10K |
| Q3 2020 | share | Increase | +11.32% | 560 shares | -3K | $559.78 | 5.50K |
| Q2 2020 | share | Increase | +60.79% | 1.87K shares | 1.58M | $623.65 | 4.94K |
| Q1 2020 | share | Increase | +10.81% | 300 shares | 460K | $488.29 | 3.07K |
| Q4 2019 | share | Decrease | -12.59% | -400 shares | 161K | $375.48 | 2.77K |
| Q3 2019 | share | Increase | +33.67% | 800 shares | 138K | $277.4 | 3.17K |
| Q2 2019 | share | Increase | +206.19% | 1.6K shares | 424K | $313 | 2.37K |
| Q1 2019 | share | Increase | +14.79% | 100 shares | 67K | $410.62 | 776 |
| Q4 2018 | share | 0.00% | 0 shares | -21K | $373.5 | 676 | |
| Q3 2018 | share | Decrease | -54.20% | -800 shares | -236K | $404.04 | 676 |
| Q2 2018 | share | Increase | +25.51% | 300 shares | 104K | $344.99 | 1.47K |
| Q1 2018 | share | 0.00% | 0 shares | -37K | $344.36 | 1.17K | |
| Q4 2017 | share | Decrease | -20.33% | -300 shares | -218K | $375.96 | 1.17K |
| Q3 2017 | share | 0.00% | 0 shares | -65K | $447.12 | 1.47K | |
| Q2 2017 | share | 0.00% | 0 shares | 153K | $491.14 | 1.47K | |
| Q1 2017 | share | Decrease | -65.48% | -2.8K shares | -998K | $387.51 | 1.47K |
| Q4 2016 | share | Decrease | -94.20% | -69.42K shares | -1.22M | $367.09 | 4.27K |
| Q3 2016 | share | Increase | +1003.95% | 67.02K shares | 459K | $402.02 | 73.7K |
| Q2 2016 | share | 0.00% | 0 shares | -75K | $349.23 | 6.67K | |
| Q1 2016 | share | Decrease | -18.35% | -1.5K shares | -2.03M | $360.44 | 6.67K |